Eric A. Adams
2024
In 2024, Eric A. Adams earned a total compensation of $415.4K as President, Chief Executive Officer and Director at InMed Pharmaceuticals, a 13% increase compared to previous year.
Compensation breakdown
| Bonus | $73,500 |
|---|---|
| Option Awards | $47,800 |
| Salary | $294,100 |
| Total | $415,400 |
Adams received $294.1K in salary, accounting for 71% of the total pay in 2024.
Adams also received $73.5K in bonus and $47.8K in option awards.
Rankings
In 2024, Eric A. Adams' compensation ranked 101st out of 152 executives tracked by ExecPay. In other words, Adams earned more than 33.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 101 out of 152 | 34th |
Division Manufacturing | 43 out of 66 | 35th |
Major group Chemicals And Allied Products | 15 out of 26 | 42nd |
Industry group Drugs | 15 out of 26 | 42nd |
Industry Pharmaceutical Preparations | 14 out of 23 | 39th |
Source: SEC filing on October 28, 2024.
Adams' colleagues
We found five more compensation records of executives working with Eric A. Adams at InMed Pharmaceuticals in 2024.
2024
Michael Woudenberg
InMed Pharmaceuticals
Chief Operating Officer
2024
Eric Hsu
InMed Pharmaceuticals
Senior Vice President, Preclinical Research & Development
2024
Alexandra Mancini
InMed Pharmaceuticals
Senior Vice President, Clinical & Regulatory Affairs
2024
Netta Jagpal
InMed Pharmaceuticals
Chief Financial Officer
2024
Jonathan Tegge
InMed Pharmaceuticals
Chief Financial Officer
News
InMed Pharmaceuticals CEO Eric Adams' 2024 pay rises 13% to $415K
October 28, 2024
InMed Pharmaceuticals CEO Eric Adams' 2023 pay falls 22% to $368K
October 27, 2023
InMed Pharmaceuticals CEO Eric Adams' 2022 pay falls 36% to $468K
October 28, 2022
InMed Pharmaceuticals CEO Eric Adams' 2021 pay jumps 73% to $735K
October 28, 2021